Cargando…

Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD)

OBJECTIVE: To evaluate the reliability and validity of the Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD). METHODS: The study consisted of six phases: item generation, reliability analysis (112 dysosmic patients for internal consistency analysis and 61 for test-rete...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardella, Arianna, Riva, Giuseppe, Preti, Andrea, Albera, Andrea, Luzi, Livio, Albera, Roberto, Cadei, Davide, Motatto, Gian Marco, Omenetti, Filippo, Pecorari, Giancarlo, Ottaviani, Francesco, Mozzanica, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366567/
https://www.ncbi.nlm.nih.gov/pubmed/37224170
http://dx.doi.org/10.14639/0392-100X-N2212
Descripción
Sumario:OBJECTIVE: To evaluate the reliability and validity of the Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD). METHODS: The study consisted of six phases: item generation, reliability analysis (112 dysosmic patients for internal consistency analysis and 61 for test-retest reliability analysis), normative data generation (303 normosmic subjects), validity analysis (comparison of Brief-IT-QOD scores of healthy and dysosmic subjects and scores correlation with psychophysical olfactory testing TDI and SNOT-22 scores), responsiveness analysis (10 dysosmic chronic rhinosinusitis with nasal polyps patients before and after biologic therapy), and cut-off value determination (ROC curve analysis of Brief-IT-QOD sensitivity and specificity). RESULTS: All subjects completed the Brief-IT-QOD. Internal consistency (α > 0.70) and test-retest reliability (ICC > 0.7) were acceptable and satisfactory for both questionnaire subscales. A significant difference between dysosmic and control subjects was found in both subscales (p < 0.05). Significant correlations between subscales scores and TDI and SNOT-22 scores were observed. Brief-IT-QOD scores before treatment were significantly higher than after biological therapy. CONCLUSIONS: Brief-IT-QOD is reliable, valid, responsive to changes in QoL, and recommended for clinical practice and outcome research.